Answers are grounded in this paper and cite their sources.
Hypertension is a frequent and underappreciated complication of cancer and its treatments, necessitating individualized antihypertensive management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Małyszko et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: